Stemcell United Ltd. (AU:BP8) has released an update.
BPH Global Limited has announced a strategic push in their biotechnology ventures, including securing a bird’s nest supply agreement in China and refining their R&D program to focus on non-pyrolytic mineral extraction from seaweed. The company has seen a decrease in cash reserves but is looking to raise capital through a share placement approved by shareholders. These developments are part of a 120-day business plan which includes expanding their market presence ahead of the Mid-Autumn Festival and engaging with Chinese banks for corporate gifting programs.
For further insights into AU:BP8 stock, check out TipRanks’ Stock Analysis page.
